Long regarded as a transitional phase, prediabetes occupies a clinical grey zone—seemingly reversible, yet increasingly recognized as metabolically active and consequential. It represents more than a warning sign—it is a critical window for action. As endocrinologists, we find ourselves on the front lines of a global metabolic crisis, with nearly one in three adults meeting diagnostic criteria.